BioMed Research International

BioMed Research International / 2016 / Article

Corrigendum | Open Access

Volume 2016 |Article ID 2676598 | https://doi.org/10.1155/2016/2676598

Jaeson Santos Calla-Choque, Elisa Elvira Figueroa-Angulo, Leticia Ávila-González, Rossana Arroyo, "Corrigendum to “α-Actinin TvACTN3 of Trichomonas vaginalis Is an RNA-Binding Protein That Could Participate in Its Posttranscriptional Iron Regulatory Mechanism”", BioMed Research International, vol. 2016, Article ID 2676598, 2 pages, 2016. https://doi.org/10.1155/2016/2676598

Corrigendum to “α-Actinin TvACTN3 of Trichomonas vaginalis Is an RNA-Binding Protein That Could Participate in Its Posttranscriptional Iron Regulatory Mechanism”

Received03 Mar 2016
Accepted23 May 2016
Published19 Jul 2016

In Figures (a)–(d) of the published article titled “α-Actinin TvACTN3 of Trichomonas vaginalis Is an RNA-Binding Protein That Could Participate in Its Posttranscriptional Iron Regulatory Mechanism” [1], we mistakenly used the same strip data in panel (a), lanes 3 and 4; panel (b), lanes 3 and 4; panel (c), lanes 2 and 4; and panel (d), lanes 2 and 3. The corrected new Figure 7 and legend are presented here.

References

  1. J. S. Calla-Choque, E. E. Figueroa-Angulo, L. Ávila-González, and R. Arroyo, “α-Actinin TvACTN3 of Trichomonas vaginalis is an RNA-binding protein that could participate in its posttranscriptional iron regulatory mechanism,” BioMed Research International, vol. 2014, Article ID 424767, 20 pages, 2014. View at: Publisher Site | Google Scholar

Copyright © 2016 Jaeson Santos Calla-Choque et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.


More related articles

435 Views | 219 Downloads | 0 Citations
 PDF Download Citation Citation
 Download other formatsMore
 Order printed copiesOrder

Related articles

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.